Structural Formula (Ceftriaxone For Injection 1)
Ceftriaxone Injection, Powder, For Solution
Product Images NDC 72572-062
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ceftriaxone (NDC 72572-062). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Civica, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
1 G Vial (Ceftriaxone For Injection 2)
This is a prescription drug called Ceftriaxone, used for IV or IM use and available in a single-dose vial. The drug contains 1 gram of Ceftriaxone and needs protection from light. It can be reconstituted with Lidocaine Hydrochloride Injection or Sterile Water for Injection. The appropriate dosage and storage instructions can be found on the package insert, and the drug should be stored at controlled room temperatures. It is distributed by Civica Inc. based in Utah and manufactured by Hikma Farmacautca in Portugal. The NDC number is 72572-061-01. The lot number is not available.*
1 G Sp (Ceftriaxone For Injection 3)
This is a description of Ceftriaxone For Injection, USP which is a medicine used for intravenous or intramuscular injection. It comes in 25 single dose vials, with each vial containing Ceftriaxone Sodium powder equal to 1 gram of Ceftriaxone. It is distributed by Givica, Inc., Leh, Utah 84043 and manufactured by Hikma Farmacéutica (Portuga), S A. The text includes instructions for reconstitution and dosage guidelines. It is important to store the powder at 20°10 to 25°C prior to reconstitution and protect the solution from light after reconstitution.*
2 G V (Ceftriaxone For Injection 4)
This is a product description of a medication with the National Drug Code (NDC) 72572-062-01. The medication is indicated for intramuscular and intravenous administration. For intramuscular administration, it requires reconstitution with 4.2 mL of 1% Lidocaine Hydrochloride Injection, USP or sterile water. For intravenous administration, it should be reconstituted with 162 mL of an IV diluent specified in the accompanying package insert. Each 1 mL of the solution contains around 350g equivalent of Ceftriaxone, USP equivalent to 2 grams Ceftriaxone. It is manufactured and distributed by Hikma Pharmaceuticals (Portugal), S.A.*
2 G Sp (Ceftriaxone For Injection 5)
Ceftriaxone For Injection, USP is a medication provided in single-dose vials, each containing 2 grams of Ceftriaxone. These vials are suitable for Intravenous or Intramuscular usage. This medication is distributed by Civica, Inc., Lohi, Utah and marketed by Hikma Farmaceutica (Portugal), S.A. The recommended dosages of Ceftriaxone are mentioned in the package insert. The powder should be stored at 20°C to 25°C (68°F to 77°F) until reconstitution. Ensure to protect the solution from light after reconstitution. To prepare for administration, the user can reconstitute the solutions with the specified diluent indicated in the package.*
Layout 1 (Ceftriaxone For Injection 6)
This text contains product identification and tracking information. It includes the GTIN (Global Trade Item Number) and SN (Serial Number) along with the expiration date (MMMYYYY) and LOT number (ABCDE12345). This information helps to uniquely identify and locate specific products in case of recalls or quality issues.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
